The EPSRC and MRC Systems Approaches to Biomedical Science CDT is an innovative 4-year D.Phil. programme in which every student works in collaboration with industry, conducting cutting edge research in:
- Computational and structural approaches underpinning drug and therapy discovery
- Data-driven drug discovery
- Physiological modelling underpinning drug discovery
We are an open collaboration between Oxford and 15 partner organisations (currently AstraZeneca, Diamond Light Source, e-Therapeutics, Evotec, GE Healthcare, GlaxoSmithKline, Hoffmann La Roche, InhibOx, Lilly UK, MedImmune, Moffitt Cancer Center, Novartis, Pfizer, Structural Genomics Consortium and UCB, and we also have students working on projects with Microsoft and Silver Creek).
We encourage applications from students with a wide range of academic backgrounds, including Mathematics, Computing, Statistics, Chemistry, Biochemistry, Physics, Biology, Pharmacology and Engineering. Fully funded studentships for home and EU students are now available.
Please explore the links website to find more information about the programme and the research training provided, as well as funding available and instructions on how to apply.
The Doctoral Training Centre is a member of the Graduate Academic Programme (GAP) and fully supports the teaching and training of graduate students across the University of Oxford.
Please note that this programme is still open and accepting applications for entry in 2015-16 . The deadline for applications is Friday 26 June 2015.
Note: In Oxford, the degree qualification commonly referred to as a Doctorate of Philospohy or Ph.D. is known as a D.Phil.